Clinical Trials on Femoral Popliteal Occlusion in Switzerland

Total 317 results

Novartis Pharmaceuticals

Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRYSTAL)

Central Retinal Vein Occlusion | Macular Edema

Greece, Hungary, Turkey, Australia, Austria, Netherlands, United Kingdom, Italy, Spain, Ireland, Portugal, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
Somahlution LLC

Active, not recruiting

EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC] (VASC)

Cardiovascular Diseases | Coronary Artery Disease

Spain, Austria, Ireland, Switzerland, Germany, Italy, Turkey, United Kingdom
Bayer

Completed

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD) (GadaCAD 1)

Coronary Artery Disease

New Zealand, United Kingdom, United States, France, Germany, Korea, Republic of, Switzerland
Weill Medical College of Cornell University

Completed

COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM) (CONFIRM)

Coronary Artery Disease | Cardiovascular Disease | Atherosclerosis

United States, Austria, Italy, Switzerland, Korea, Republic of, Germany, Canada
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Branch Retinal Vein Occlusion

China, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Sanofi

Completed

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Arteriosclerosis

France, Canada, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United States, Turkey, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finlan... and more
Abbott Medical Devices

Completed

Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy (VTACH)

Coronary Artery Disease | Ventricular Tachycardia | Left Ventricular Dysfunction

Germany, Switzerland, Czechia, Denmark
Aarhus University Hospital Skejby
Medis Medical Imaging Systems

Active, not recruiting

Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Japan Study (FAVOR III EJ)

Coronary Artery Disease

Spain, Denmark, Sweden, Italy, Lithuania, Netherlands, Germany, France, Latvia, Poland, Switzerland
Biotronik AG

Unknown

Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent (BIOFLOW-IV)

Coronary Artery Disease

Spain, Germany, Switzerland, Japan, Netherlands, Sweden, Australia, Belgium, Denmark, Israel, New Zealand, Poland
Bayer

Completed

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Peripheral Vascular Diseases

Germany, Switzerland, Argentina, Austria, Mexico, Brazil
Biotronik AG

Completed

BIOLUX P-III All-Comers Passeo-18 Lux Registry

Atherosclerosis | Peripheral Artery Disease

France, Germany, Spain, Belgium, Singapore, Austria, Netherlands, Malaysia, Italy, Switzerland, Denmark, Portugal, Australia, Finland, Latvia, Slovakia
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

Muscle Wasting (Atrophy) After Hip Fracture Surgery

Colombia, Belgium, Hungary, Taiwan, Spain, Czechia, United States, France, Germany, Turkey, Japan, Russian Federation, United Kingdom, Argentina, Australia, Mexico, Chile, Switzerland, Austria
Medstar Health Research Institute

Completed

Drug Eluting Stent Registry of Thrombosis (DESERT)

Coronary Artery Disease

United States, Switzerland, Canada
Deutsches Herzzentrum Muenchen

Unknown

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE)

Coronary Artery Disease

Germany, Denmark, New Zealand, Japan, Belgium, Switzerland, United States, Albania, Austria, China, Ireland, Italy, Netherlands
Genzyme, a Sanofi Company

Terminated

Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Ischemic Heart Disease | Ischemic Cardiomyopathy | Ischemic Heart Failure

Belgium, France, Germany, Italy, Switzerland, United Kingdom
Daiichi Sankyo, Inc.
UMC Utrecht

Completed

Edoxaban in Peripheral Arterial Disease (ePAD)

Peripheral Arterial Disease

United States, Germany, Switzerland, Israel, Netherlands, Austria, Belgium
Bayer
Regeneron Pharmaceuticals

Recruiting

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) (QUASAR)

Macular Edema Secondary to Retinal Vein Occlusion

Korea, Republic of, Japan, China, Lithuania, United States, Italy, Spain, Hungary, Israel, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Germany, Latvia, Mal... and more
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
University Hospital, Basel, Switzerland
Bristol-Myers Squibb; Swiss National Science Foundation

Completed

Cardiovascular Risk Factor Management in HIV Infection

HIV Infection | Dyslipidemia | Coronary Heart Disease | Diabetes Mellitus, Non-Insulin-Dependent

Switzerland
Medtronic Endovascular

Completed

IN.PACT Global Clinical Study

Peripheral Arterial Disease

Korea, Republic of, Belgium, Germany, Hungary, Singapore, Canada, Austria, United Kingdom, Australia, Argentina, Netherlands, Italy, Slovenia, Colombia, Czechia, Egypt, Finland, France, Greece, Israel, Lithuania, Poland, Portugal, Russian... and more
CeloNova BioSciences, Inc.

Completed

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Coronary Artery Disease

United States, Spain, Serbia, France, Switzerland, Germany, Latvia
Deutsches Herzzentrum Muenchen
AstraZeneca

Terminated

Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG (TiCAB)

Coronary Artery Disease | Acute Coronary Syndrome | Stable Angina

Germany, Austria, Switzerland
M.A. Med Alliance S.A.

Recruiting

The SELUTION DeNovo Study

Coronary Artery Disease

Netherlands, France, Switzerland, Czechia, United Kingdom, Spain, Singapore, Germany, Austria, Italy, Finland, Poland
Biotronik AG

Completed

Bioflow-DAPT Study

Coronary Artery Disease

Hong Kong, Thailand, France, Latvia, Belgium, Singapore, Switzerland, Spain, New Zealand, Austria, Australia, Malaysia, Denmark, Italy, Germany, Netherlands, Hungary, Poland
Biosensors Europe SA

Completed

e-BioMatrix PostMarket Registry (eBMX-PMR)

Coronary Artery Disease

United Kingdom, Spain, France, Ireland, Switzerland, Germany, Denmark, Austria, Latvia, Czechia, Jordan, Lithuania, Morocco, Poland, Portugal, Russian Federation
Abbott Medical Devices

Completed

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Switzerland, Netherlands, Spain, France, Sweden, Poland, Germany, Belgium, Denmark, Italy, United Kingdom
C. R. Bard

Completed

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Peripheral Artery Disease

United States, Germany, Belgium, Austria, Switzerland
Biotronik AG

Unknown

BIOFLOW-III All-comers Orsiro Safety and Performance Registry (BIOFLOW-III)

Myocardial Ischemia | Coronary Artery Disease

Germany, Latvia, Spain, Netherlands, Italy, Austria, Chile, Denmark, France, Portugal, Sweden, Switzerland, United Kingdom
GE Healthcare
Pharmaceutical Product Development, LLC

Completed

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)

United States, Germany, Switzerland, Canada, Netherlands, France, Finland
European Cardiovascular Research Center

Unknown

Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (PLATINUM+)

Ischemic Heart Disease | Coronary Artery Stenosis

Spain, Germany, France, United Kingdom, Italy, Netherlands, Macedonia, The Former Yugoslav Republic of, Switzerland
Sanofi

Completed

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)

Peripheral Vascular Diseases

France, Canada, Brazil, Poland, Russian Federation, Ukraine, Germany, Spain, Sweden, Switzerland, United States, Turkey, Singapore, Belgium, Czech Republic, Mexico, Japan, Austria, Denmark, Finland, Hungary, Italy, Korea, Republic of, Chil... and more
Sanofi
Bristol-Myers Squibb

Completed

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS (CURRENT/OASIS7)

Acute Coronary Disease | Angina Unstable

United States, France, Canada, Brazil, Poland, Romania, Russian Federation, Germany, Italy, Netherlands, Sweden, Switzerland, Turkey, Bulgaria, Estonia, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Chile, Cr... and more
Sino Medical Sciences Technology Inc.
Nova Vascular LLC

Active, not recruiting

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

Coronary Artery Disease

Spain, United States, Netherlands, Belgium, Switzerland, United Kingdom, Canada, Japan
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Bayer

Completed

Gadobutrol Enhanced MRA of the Renal Arteries (GRAMS)

Renal Artery Obstruction

Taiwan, United States, Korea, Republic of, France, Turkey, Switzerland, Austria, Poland, Brazil, Colombia, Germany, Czech Republic, Argentina
Abbott Medical Devices

Completed

ABSORB EXTEND Clinical Investigation (ABSORB EXTEND)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Netherlands, Taiwan, China, New Zealand, Singapore, France, United Kingdom, Austria, Israel, Italy, Malaysia, India, Poland, Sweden, Spain, South Africa, Canada, Australia, Japan, Argentina, Brazil, Switzerland, Belgium, Denmark, Germany
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Bayer

Completed

Gadobutrol Enhanced MRA of the Supra-aortic Vessels (GEMSAV)

Carotid Stenosis

France, China, United States, Austria, Poland, Australia, Italy, Turkey, Germany, Korea, Republic of, Sweden, Switzerland, Czechia, Argentina
University Medical Center Goettingen

Completed

Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe (EU-CERT-ICD)

Myocardial Infarction | Coronary Artery Disease | Dilated Cardiomyopathy | Implantable Defibrillator User

Hungary, Poland, Belgium, Bulgaria, Croatia, Czechia, Denmark, Finland, Germany, Greece, Netherlands, Slovakia, Spain, Sweden, Switzerland, United Kingdom
Philips Clinical & Medical Affairs Global

Enrolling by invitation

Distal Evaluation of Functional Performance With Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting (DEFINE GPS)

Coronary Artery Disease | Ischemic Heart Disease

United States, Netherlands, Denmark, Sweden, Canada, Israel, United Kingdom, Spain, Australia, Germany, Switzerland, Austria, Belgium, France, Portugal, Mexico
ECRI bv
AstraZeneca; The Medicines Company; Biosensors International

Completed

GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

Coronary Artery Disease (CAD)

Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Portugal, Singapore, Spain, Switzerland, United Kingdom
Boston Scientific Corporation

Completed

EVOLVE Short DAPT Study

Coronary Artery Disease

United States, Germany, Latvia, Japan, Sweden, Brazil, Switzerland
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
MedAlliance, LLC
NAMSA

Recruiting

SELUTION4BTK Trial

Peripheral Arterial Disease | Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities

United States, Switzerland, New Zealand, Italy, Singapore, Hong Kong, Netherlands, France, Germany, Austria
University of Oxford
NHS Health Technology Assessment Programme; BUPA Foundation

Unknown

Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients (ACST-2)

Carotid Stenosis

Germany, Italy, Israel, United Kingdom, Croatia, Switzerland, China, Canada, Austria, Sweden, Spain, Belgium, Czechia, France, United States, Brazil, Bulgaria, Egypt, Estonia, Greece, Hungary, Ireland, Japan, Kazakhstan, Netherlands, Norway, Pola... and more
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST 2)

Diabetes Mellitus, Type 2 | Dyslipidemia | Peripheral Vascular Disease | Coronary Arteriosclerosis | Cerebrovascular Accident

Greece, Ireland, Russian Federation, Slovakia, Poland, Hungary, Portugal, Switzerland
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Abiomed Inc.

Recruiting

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

Coronary Artery Disease | Left Ventricular Dysfunction

United States, Switzerland, Germany, Canada, Italy, Netherlands, United Kingdom
Novartis Pharmaceuticals

Recruiting

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (V-PLAQUE)

Coronary Artery Disease

United States, Italy, Spain, France, Korea, Republic of, Hungary, Japan, Argentina, China, India, Belgium, Switzerland, United Kingdom, Canada, Australia, Brazil, Chile, Ireland

Clinical Trials on Femoral Popliteal Occlusion in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations